Form 4 for TKR TIMKEN CO
Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-17 · accession 0000098362-23-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-21 | 2023-02-17 | TKR | Fracassa Philip D. | EVP, CFO | F - Tax | $86.10 | -5,374 | 118.3K | -4% | -$462.7K |
| D | 2023-02-21 | 2023-02-17 | TKR | Fracassa Philip D. | EVP, CFO | S - Sale+OE | $85.77 | -19.5K | 98.9K | -16% | -$1.67M |
| D | 2023-02-21 | 2023-02-17 | TKR | Fracassa Philip D. | EVP, CFO | M - OptEx | $42.60 | +24.8K | 123.7K | +25% | +$1.06M |
| D | 2023-02-21 | 2023-02-17 | TKR | Fracassa Philip D. | EVP, CFO | M - OptEx | $0.00 | +24.8K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-17 | F | D | 5,374 | $86.10 | 118,319 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-17 | S | D | 19,451 | $85.77 | 98,868 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $85.34 to $86.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2023-02-17 | M | A | 24,825 | $42.60 | 123,693 | D | — | — | |
| 4 | Derivative | Employee Stock Options (right to buy) | 2023-02-17 | M | A | 24,825 | $0.00 | 0 | D | $42.60 · 2020-02-12 to 2029-02-12 | 24,825 Common Stock | (F2) 24,825 stock options from 2/12/2019 grant of 34,825 stock options (previously reported) that vested in 25% increments per year from the date of grant. |